Table 1.
PDZ domains used for MD simulations.
Protein | PDZ | Class | PDB code | Residue Ids | Ligand Length | Ligand Sequencea |
---|---|---|---|---|---|---|
NHERF |
PDZ1 |
Apo | 1G9O93 | A:10−94 | ||
I | 1GQ518 | A:10−94/A:95−99 | 5 | -EDSFL (`a' pep.) | ||
I | 1GQ418 | A:10−94/A:95−99 | 5 | -NDSLL (`b' pep.) | ||
I |
1I9233 |
A:10−94/A:95−99 |
5 |
-QDTRL (`c' pep.) |
||
PSD-95 |
PDZ3 |
Apo | 1BFE3 | A:306−415 | ||
I |
1BE93 |
A:306−415/B:5−9 |
5 |
-KQTSV |
||
Dishevelle d |
Apo | 1L6O32 | A:254−340 | |||
|
I |
1L6O32 |
A:254−340/D:1−8 |
8 |
-SLKLMTTV |
|
Shankb |
Apo | 1Q3O34 | A:584−686 | |||
|
I |
1Q3P34 |
A:584−686/C:1−6 |
6 |
-EAQTRL |
|
Syntenin |
PDZ2 |
Apo | 1NTE21 | A:197−270 | ||
I | 1OBX21 | A:197−270/B:5−8 | 4 | -(ETLE)DSVF | ||
II |
1OBY21 |
B:197−270/Q:1−6 |
6 |
-TNEFYA |
||
Erbin |
Apo | 1MFG20 | A:1280−1367 | |||
I | 1N7T30 | model 2 A:12−99/B:301−307 | 7 | -TGWETWV | ||
|
II |
1MFG20 |
A:1280−1367/B:1247−1255 |
9 |
-EYLGLDVPV |
|
GRIP |
PDZ6 |
Apo | 1N7E94 | A:668−753 | ||
II |
1N7F94 |
A:668−753/B:1−8 |
8 |
-ATVRTYSC |
||
Inad | PDZ1 | Apo | 1IHJ.31 | A:12−105 | ||
II | 1IHJ.31 | A:12−105/D:3−7 | 5 | -(GK)TEFCA |
Residues in parenthesis are disordered in the crystal structure and were not included in the MD simulations.
The coordinates of residues 602 to 621 in the holo structure were taken from the crystal structure of the apo form of Shank (PDB code: 1Q3O), see “Molecular Systems” subsection in Materials and Methods.